Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ATERIAN PLC Director's Dealing 2023

Aug 17, 2023

5115_dirs_2023-08-17_44482512-ab37-424e-907c-20fbebc17dbd.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6520J

Aterian PLC

17 August 2023

ATERIAN Plc

("Aterian ", the "Company" or the "Group")

Director/PDMR Share Purchases

Aterian Plc (LSE: ATN), the exploration and development company advancing its portfolio of African-focused critical and strategic metal assets was informed on 10 August 2023 of the following purchases of the Company's ordinary shares by Directors and PDMRs of the Company.

The purchases made on 10 August 2023 are detailed below:

1.       

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Charles Bray

2.       

Reason for the notification

a)

Position/status

PDMR, Director

b)

Initial notification / Amendment

3.       

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aterian plc

b)

LEI

2138005GAARIE1JMP262

4.       

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

ISIN: GB00BKS7ZV87

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price (s) Volume (s)
£0.01 20,000,000

d)

Aggregate information

- Aggregate volume

20,000,000 shares in aggregate

- Total Price

£200,000

e)

Date of the transaction

10/08/2023

f)

Place of the transaction

London Stock Exchange

g)

Additional information

NA

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPRMLTMTABMJJ